REAC (Radio Electric Asymmetric Conveyer) Technology® is an innovative technology platform developed in Italy. Through specific hardware and software configurations, it emits highly specialized low-power asymmetric radioelectric fields capable of modulating the functions of specific cell populations targeted by the treatment. The objective is to restore cellular bioelectric equilibrium, promoting tissue self-repair and regeneration processes at the organic level and reorganization of neurotransmission processes at the neurological level.
Main features of REAC Technology®:
The medical devices of the B.E.N.E. (Bio Enhancer Neuro Enhancer) family, following specific therapeutic protocols, emit controlled asymmetric radioelectric fields that are asymmetrically conveyed to the patient in specific treatment areas through A.C.P. (Asymmetric Conveyer Probe).
These interact with cellular bioelectric activity, stimulating the reorganization of neurotransmission processes altered by trauma, disorders, or pathologies, thereby promoting healing.
Treatments take only a few minutes and are safe, painless, with no side effects. Sessions require at least a one-hour interval between them but can be repeated up to four times within the same day.
This feature facilitates faster patient recovery and minimizes logistical challenges. Simultaneously, it enables practitioners to deliver a high volume of treatments daily, leading to greater professional and economic satisfaction.



REAC Technology® has been the subject of numerous publications in international scientific journals, validating its therapeutic approach in areas such as:
Mood and behavior disorders
Postural and motor disorders
Treatment of pain syndromes
Treatment for repair/regenerative processes
Anti-aging and cellular longevity
These scientific findings confirm that REAC Technology® represents an innovative and scientifically validated approach for treating numerous conditions by acting on the fundamental bioelectric mechanisms that regulate cellular and tissue functions.


Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V